Counsel / Sr. Counsel, Transactions
We are seeking an energetic transactional attorney to serve as in-house counsel to complement our efforts in creating a very special company focused on transformative cutting edge medicines. This dynamic individual will be instrumental in supporting the business needs of the company by serving as the primary legal contact for transactional matters and related contracting. The position will also establish and/or support third party alliances and collaborations and advise the company with respect to protecting and enhancing the value of such partnerships. In addition, the attorney will oversee and manage both legal and compliance issues associated with Government contracts.
- Drafting and negotiating of a wide range of agreements, including complex licenses and collaboration agreements.
- Managing high volume R&D related agreements, including confidentiality, material transfer, master service, consulting, and clinical trial agreements.
- Supporting alliance management activities and governance of programs.
- Support government grants and related compliance efforts.
- Shape company policies and procedures.
- Juris Doctor from an accredited U.S. law school.
- Admitted to at least one State Bar.
- Prior in-house or law firm experience in the pharmaceutical or biotech industry, including transactional matters that impact R&D.
- Excellent drafting and negotiation skills.
- A demonstrated ability to grasp scientific and technical concepts quickly.
- Demonstrated ability to collaborate, as well as to work independently, balancing competing priorities in a fast-paced environment.
- Familiarity with administration and compliance efforts associated with government grants.
- A technical background in molecular biology, biochemistry, or organic chemistry.
- Highly effective communication (both verbal and written).
- Results orientation.
- Detail orientation balanced with pragmatism.
Why join Moderna Therapeutics
Moderna Therapeutics is pioneering messenger RNA therapeutics™, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. This breakthrough platform addresses currently undruggable targets and offers a superior alternative to existing drug modalities for a wide range of disease conditions. Moderna has developed a broad intellectual property estate including 200 patent applications with 10,000 claims ranging from novel nucleotide chemistries to specific drug compositions. The company plans to develop and commercialize its innovative mRNA drugs—initially for rare diseases and oncology—while partnering drug candidates in other therapeutic areas in order to rapidly deliver this innovation to patients.
Based in Cambridge, Massachusetts, Moderna is privately held and was founded in 2010 by Flagship VentureLabs in association with leading scientists from Harvard University and Massachusetts Institute of Technology.
Moderna recently signed a collaboration agreement with Astra Zeneca that provided a $240MM upfront payment (plus milestone payments).
Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Moderna will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Visit http://modernatx.com/revolution to apply.